Anupam Rama Analyst Performance

Analyst at JPMorgan Chase & Co.

Anupam Rama is a stock analyst at JPMorgan Chase & Co. focused in the healthcare sector, covering 47 publicly traded companies. Over the past year, Anupam Rama has issued 58 stock ratings, including buy, hold, and sell recommendations. While full access to Anupam Rama's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anupam Rama's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
158 Last 11 Years
Buy Recommendations
82.91% 131 Buy Ratings
Companies Covered
47 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy82.9%131 ratings
Hold13.9%22 ratings
Sell3.2%5 ratings

Out of 158 total stock ratings issued by Anupam Rama at JPMorgan Chase & Co., the majority (82.9%) have been Buy recommendations, followed by 13.9% Hold and 3.2% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
47 companies

Anupam Rama, an analyst at JPMorgan Chase & Co., currently covers 47 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
45 companies
95.7%
Miscellaneous
1 company
2.1%
Industrials
1 company
2.1%

Anupam Rama of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector, with additional focus on and Industrials companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
43 companies
91.5%
PHARMACEUTICALS
2 companies
4.3%
Miscellaneous
1 company
2.1%
ELECTRICAL EQUIPMENT
1 company
2.1%

Anupam Rama's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
11/12/2026Boost Price Target$2.13$12.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
11/11/2026Lower Price Target$37.17$51.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
11/6/2026Lower Price Target$49.60$86.00Overweight
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
10/30/2026Boost Price Target$92.24$122.00Overweight
ETRA
Electra Therapeutics
10/22/2026Initiated Coverage$9.05$36.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
10/14/2026Boost Price Target$11.31$26.00Overweight
C4 Therapeutics, Inc. stock logo
CCCC
C4 Therapeutics
10/9/2026Initiated Coverage$2.85$10.00Overweight
Annexon, Inc. stock logo
ANNX
Annexon
9/30/2026Boost Price Target$4.23$15.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
9/30/2026Lower Price Target$18.33$20.00Neutral
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
9/30/2026Lower Price Target$50.61$60.00Overweight
Celcuity, Inc. stock logo
CELC
Celcuity
9/17/2026Initiated Coverage$82.58$157.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
9/8/2026Boost Price Target$35.10$83.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/3/2026Downgrade$26.53$36.00Neutral
Annexon, Inc. stock logo
ANNX
Annexon
9/1/2026Boost Price Target$4.86$14.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
8/26/2026Boost Price Target$15.27$21.00Overweight
KARD
Kardigan
8/25/2026Lower Price Target$20.64$46.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/25/2026Boost Price Target$25.72$80.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/13/2026Lower Price Target$10.43$46.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
8/13/2026Lower Price Target$3.36$11.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
8/12/2026Boost Price Target$83.73$111.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
8/11/2026Lower Price Target$20.19$40.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
8/7/2026Boost Price Target$12.25$20.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/3/2026Boost Price Target$41.65$66.00Overweight
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
7/29/2026Boost Price Target$81.03$107.00Overweight
KARD
Kardigan
7/13/2026Initiated Coverage$24.64$51.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
6/26/2026Upgrade$10.95$17.00Overweight
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
6/16/2026Upgrade$3.96$9.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
5/29/2026Upgrade$8.61$8.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/8/2026Boost Price Target$152.28$185.00Overweight
TRAX
First Tracks Biotherapeutics
4/23/2026Initiated Coverage$18.87$31.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
4/13/2026Downgrade$4.77Underweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
4/1/2026Downgrade$40.39$41.00Neutral
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
3/31/2026Boost Price Target$30.20$58.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
3/25/2026Lower Price Target$27.14$41.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/25/2026Boost Price Target$7.28$12.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/18/2026Boost Price Target$14.45$58.00Overweight
Erasca, Inc. stock logo
ERAS
Erasca
3/18/2026Boost Price Target$13.51$25.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/18/2026Lower Price Target$18.92$32.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/16/2026Upgrade$7.86$12.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
3/12/2026Boost Price Target$128.49$177.00Overweight
I'm handing you this one free (Ad)

Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel

See today's free stock pick before the December 8th deadline here
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
3/12/2026Lower Price Target$21.44$74.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/11/2026Downgrade$21.31$21.50Neutral
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
3/10/2026Boost Price Target$74.18$94.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/9/2026Boost Price Target$24.74$45.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/5/2026Boost Price Target$20.15$37.00Overweight
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
3/3/2026Initiated Coverage$16.21$32.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/17/2026Lower Price Target$128.66$176.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
2/5/2026Lower Price Target$17.25$39.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
1/12/2026Lower Price Target$132.91$177.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
12/19/2025Lower Price Target$50.24$96.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
12/19/2025Boost Price Target$38.89$67.00Overweight
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
12/19/2025Lower Price Target$12.84$40.00Overweight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
12/19/2025Lower Price Target$103.23$145.00Overweight
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
12/9/2025Initiated Coverage$8.36$43.00Overweight
Novavax, Inc. stock logo
NVAX
Novavax
11/18/2025Lower Price Target$6.56$6.00Underweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/18/2025Boost Price Target$11.70$20.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
11/18/2025Boost Price Target$21.48$32.00Overweight
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/17/2025Downgrade$217.78Neutral
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
11/14/2025Initiated Coverage$11.72$17.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
11/12/2025Lower Price Target$16.78$33.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
11/12/2025Boost Price Target$29.58$57.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
11/7/2025Boost Price Target$9.74$27.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
11/7/2025Boost Price Target$62.11$77.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
11/7/2025Lower Price Target$24.17$52.00Overweight
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
11/6/2025Boost Price Target$8.90$19.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
11/5/2025Lower Price Target$20.02$36.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
11/5/2025Lower Price Target$3.96$11.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
11/3/2025Boost Price Target$140.28$179.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
10/24/2025Upgrade$17.11$24.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
10/23/2025Boost Price Target$28.58$79.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
10/21/2025Boost Price Target$16.22$44.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/20/2025Upgrade$36.85$55.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
10/20/2025Upgrade$8.93$11.00Neutral
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
10/10/2025Initiated Coverage$110.76$200.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
9/29/2025Boost Price Target$27.00$37.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
9/19/2025Reiterated Rating$3.46Underweight
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
9/16/2025Downgrade$2.74Neutral
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
9/3/2025Boost Price Target$52.20$70.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
9/3/2025Boost Price Target$25.93$74.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/14/2025Upgrade$8.62$15.00Neutral
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/14/2025Lower Price Target$6.27$13.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.71$17.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/14/2025Boost Price Target$5.24$29.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/7/2025Boost Price Target$10.79$30.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/7/2025Lower Price Target$19.72$53.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
8/4/2025Boost Price Target$24.26$37.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Boost Price Target$128.23$145.00Neutral
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
7/30/2025Upgrade$11.53$14.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/29/2025Upgrade$13.86$24.00Neutral
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/28/2025Boost Price Target$24.50$72.00Overweight
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/25/2025Reiterated Rating$12.89Underweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
7/24/2025Boost Price Target$26.91$80.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/22/2025Reiterated Rating$3.05$9.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/21/2025Lower Price Target$14.07$20.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/16/2025Boost Price Target$12.40$19.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/10/2025Boost Price Target$11.02$29.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/10/2025Lower Price Target$19.01$28.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/29/2025Boost Price Target$5.22$25.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
5/22/2025Boost Price Target$19.04$66.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
5/20/2025Lower Price Target$37.68$84.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/28/2025Lower Price Target$4.20$28.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
3/27/2025Boost Price Target$38.88$117.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
3/26/2025Boost Price Target$116.18$184.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
3/24/2025Boost Price Target$34.77$50.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/20/2025Boost Price Target$13.84$41.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/13/2025Boost Price Target$36.14$51.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/13/2025Lower Price Target$5.15$11.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/5/2025Boost Price Target$15.19$42.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/5/2025Lower Price Target$9.32$34.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/4/2025Boost Price Target$14.46$39.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/4/2025Boost Price Target$24.65$54.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
3/4/2025Lower Price Target$28.66$71.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
2/26/2025Boost Price Target$21.45$44.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/26/2025Boost Price Target$13.60$18.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/26/2025Boost Price Target$8.69$22.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
2/25/2025Initiated Coverage$10.82$30.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/6/2025Boost Price Target$12.72$21.00Overweight